Thursday, August 20, 2026
Innovatyve Wellness Solutions
  • Home
  • Health
    • Brain Research
  • Obesity and Weight
  • Mental Health
    • Alzheimers Disease
    • Bipolar Disorder
    • Cognition
    • Depression
  • More
    • Mindfulness
    • Neuroscience
    • Relationships
  • Contact
No Result
View All Result
HealthNews
No Result
View All Result
Home Health

When Innovation Isn’t Enough: Pharma’s Next Frontier

Editorial Team by Editorial Team
December 14, 2022
in Health
0
When Innovation Isn’t Enough: Pharma’s Next Frontier
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter


When Innovation Isn’t Enough: Pharma’s Next Frontier
Michael Sheeley, Co-founder & CEO of Nurse-1-1

I met Mark Cuban as soon as. Our dialog didn’t final very lengthy.

It was at a medical convention a number of years in the past. Cuban felt like a terrific man to strategy with an concept for a healthcare startup. We have been each traders in an automation software program startup referred to as Zoba, and I after all knew him from his function on the favored entrepreneurial actuality TV sequence Shark Tank.

Just a few seconds into our dialog, Cuban paused. “Healthcare is hard,” he sighed. That was his manner of politely telling me: for that motive, I’m out.

Cuban isn’t incorrect. Healthcare is onerous. It’s a fancy world full of rules and plenty of layers of stakeholders. Innovation usually strikes slower than different industries. Still, that hasn’t stopped game-changers like Cuban’s patient-friendly Cost Plus Drug Company from breaking floor. 

Healthcare transformation is trending in the fitting route. Innovative firms are bobbing up with new value fashions and new expertise – like units to observe affected person conduct and synthetic intelligence to ship insights from that information. We’re making the mandatory transfer in direction of on-line and digital healthcare, however this shift received’t enhance the affected person expertise by itself.

We can fill low cost prescriptions on-line, or monitor our signs with a wearable gadget. Patients are extra empowered than ever, however we are able to’t afford to lose private touchpoints and human empathy in our transfer towards the digital well being future. For every innovation that brings comfort and effectivity, we’d like a counterpart that helps sufferers be proactive about pursuing the very best well being outcomes.

Complementing new pharmacy value fashions with further assist

We don’t have to get into the intricacies of pharmacy benefit managers (PBMs) and reimbursements to know the innovation underway within the pharmaceutical area. 

Here’s what we do know: a Gallup ballot from late 2021 confirmed that 18 million Americans battle to pay for prescribed medicines. 

Mark Cuban’s Cost Plus Drugs was based to bypass conventional PBMs (aka the healthcare business middlemen) and sell pharmacy drugs online – direct to shoppers –  at cheaper costs. It’s primarily a money pharmacy: no medical health insurance accepted. Cost Plus Drugs negotiate drug costs instantly with producers. Cuban’s firm prides itself on transparency, including a 15% markup and small charges for labor and delivery.

This is a serious win for sufferers. More folks can entry the prescribed drugs they must be wholesome. Kudos to you, Mr. Cuban!

But the business can’t cease innovating. Cuban’s firm is addressing one main drawback (sky-high drug costs) but additionally perpetuating one other. Those huge charges that went to middlemen additionally paid for assist methods. When you narrow out the middlemen, you additionally lose sources just like the costly nurse name facilities or pharmacists that may reply questions on the entrance desk. We’ve received considerably cheaper medicine, however fewer human touchpoints that assist reply affected person questions and drive adherence.

Pharma firms are getting extra progressive. They’ve began to create branded portals that assist sufferers arrange textual content reminders to take their medicine or refill their prescription, entry monetary help and join with nurses and suppliers. These methods are new– and never each drug has its personal – however they characterize a transfer in the fitting route. 

It’s the second wave of innovation: the mandatory changes and add-ons that assist embed assist and care into groundbreaking new concepts.

Driving impression from improved information assortment and evaluation

I’m impressed with the instruments that sufferers have at their disposal to assemble and analyze information. There are a number of examples, however I’ll point out two.

Apple Health has launched a Medications feature, which might be linked to a person’s well being information. It permits sufferers to create a medicine checklist, arrange reminders, and obtain good alerts from their iPhone or Apple Watch.

Propeller Health has developed a sensor that attaches to inhalers. These sensors monitor the place, when and the way usually a affected person makes use of their inhaler. The sensors robotically ship that info to an app on the affected person’s cellphone. AI analyzes the climate and different components to assist make applicable recommendations to the affected person.

These are stellar improvements, however I nonetheless assume we’re lacking one thing. Driving optimistic outcomes from affected person information is a three-step course of that we haven’t totally accomplished:

1. Collect affected person information. Check.

2. AI analyzes the info and gives insights. Check

3. Influence affected person behavioral change to drive outcomes with a personalised degree of care. Incomplete.

We want to assist sufferers be proactive about understanding and performing on the entire healthcare information that’s obtainable to them. They can monitor medicine on their cellphone or find out how the climate is affecting their respiration – however what do they do with that info? How ought to their conduct change when their cellphone pings them with some important perception? 

It’s not so simple as telling sufferers what to do. Patients must be educated, guided and influenced, particularly on the subject of their well being. 

To this level, robots and AI can leverage affected person information and perceive the place the affected person is of their journey. They can’t, nevertheless, successfully get the affected person to behave on what they want. I see a future the place these merchandise, very similar to drug firms, provide a extra direct, human choice to assist their sufferers. Empathy, belief and training all must be embedded into these new applied sciences.

Our information is simply pretty much as good as what we do with it – so let’s make it simpler for sufferers to behave on the precious information gathered by their progressive units, and affect them towards making the fitting healthcare selections. 

The two-front battle to enhance the affected person expertise

Every step ahead within the digital health transformation requires two forms of innovation: a groundbreaking new mannequin or resolution and a supporting useful resource that helps sufferers navigate a brand new pathway.

Healthcare is tough. But it’s not not possible. Innovation and collaboration from business leaders will make sure that we maintain discovering options to make the affected person journey simpler, extra environment friendly and simpler.

I believe Mark Cuban will surely agree with that.


About Michael Sheeley
Michael Sheeley is the Co-founder and CEO of Nurse-1-1, a HIPAA-compliant stay chat platform that connects sufferers with a nationwide community of over 2,500 NPs, RNs, PAs, and MDs. Previously he was the Co-founder and COO of RunKeeper, a cellular well being and health firm that was acquired by ASICS.





Source link

Tags: FrontierInnovationisntPharmas
Advertisement Banner
Previous Post

Monash BDI researcher recognised for outstanding contribution to neuroscience

Next Post

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Editorial Team

Editorial Team

Next Post
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Discussion about this post

Recommended

How to Build and Maintain a Friendship

How to Build and Maintain a Friendship

2 years ago
Why a Healthy Lifestyle Is Not Enough to Prevent Dementia

Why a Healthy Lifestyle Is Not Enough to Prevent Dementia

4 years ago

Don't Miss

Chronic wasting disease detected in four more Illinois counties – wandtv.com

Ebola started in DR Congo earlier and officials are playing catch-up, WHO warns – BBC

August 10, 2026
Scientists Discover a Hidden Way T Cells Attack Leukemia

Scientists Discover a Hidden Way T Cells Attack Leukemia

August 8, 2026
The Growing Disconnect Between Clinical Documentation and Reimbursement

The Growing Disconnect Between Clinical Documentation and Reimbursement

August 6, 2026
Collagen vs. Creatine vs. Colostrum: Which Is Best?

Collagen vs. Creatine vs. Colostrum: Which Is Best?

August 4, 2026

Recent News

This Common Gut-Bacteria Compound May Be Linked to Alzheimer’s Disease

This Common Gut-Bacteria Compound May Be Linked to Alzheimer’s Disease

August 18, 2026
How Multilingual AI Scribes Are Bridging Communication Gaps at the Point of Care

How Multilingual AI Scribes Are Bridging Communication Gaps at the Point of Care

August 16, 2026

Categories

  • Alzheimers Disease
  • Brain Research
  • Cognition
  • Depression
  • Health
  • Mental Health
  • Mindfulness
  • Neuroscience
  • Relationships

Follow us

Recommended

  • This Common Gut-Bacteria Compound May Be Linked to Alzheimer’s Disease
  • How Multilingual AI Scribes Are Bridging Communication Gaps at the Point of Care
  • 9 Summer Eating Habits You’re Missing to Stay Fueled and Energized
  • Why Your Skin Does Its Best Work While You Sleep
  • Ebola started in DR Congo earlier and officials are playing catch-up, WHO warns – BBC

© 2022 Psychology Aisle

No Result
View All Result
  • Home
  • Health
    • Brain Research
  • Obesity and Weight
  • Mental Health
    • Alzheimers Disease
    • Bipolar Disorder
    • Cognition
    • Depression
  • More
    • Mindfulness
    • Neuroscience
    • Relationships
  • Contact

© 2022 Psychology Aisle